Global Burden of Metabolic Diseases: Epidemiological Trends and Therapeutic Implications

Background: Metabolic diseases represent a growing global health challenge, with significant increases in prevalence, morbidity, and healthcare costs worldwide. Recent epidemiological data reveal concerning trends in disease burden across all age groups and geographic regions. Objective: This comprehensive review examines the global burden of metabolic diseases from 1990 to 2021, analyzing epidemiological trends, risk factors, and the impact of high body mass index on disease development and progression. Methods: A systematic analysis of Global Burden of Disease Study 2021 data was conducted, focusing on metabolic disease prevalence, disability-adjusted life years, and mortality patterns. Special attention was given to trends in adolescents and young adults aged 15-39 years. Results: The global burden of metabolic diseases has increased substantially over three decades, with obesity-related conditions showing the most dramatic rises. Young adults demonstrate particularly concerning trends, with significant increases in diabetes, cardiovascular disease, and metabolic syndrome prevalence. Conclusions: Urgent public health interventions are needed to address the growing burden of metabolic diseases. Comprehensive strategies targeting modifiable risk factors, particularly obesity, are essential for reversing current epidemiological trends.